Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study

Luigi Marzio Biasucci, Filippo Crea, Fulvio Bellocci, Giovanna Giubilato, Maurizio Landolina, Roberto Rordorf, Antonello Vado, Endrj Menardi, Serafino Orazi, Massimo Sassara, Antonello Castro, Riccardo Massa, Antoine Kheir, Gabriele Zaccone, Catherine Klersy, Francesco Accardi

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

12 Citazioni (Scopus)

Abstract

Patients at risk of sudden cardiac death (SCD) after myocardial infarction (MI) can be offered therapy with implantable cardioverter defibrillators (ICDs). Whether plasma biomarkers can help risk stratify for SCD and ventricular arrhythmias (VT/VF) is unclear.
Lingua originaleEnglish
pagine (da-a)1344-1350
Numero di pagine7
RivistaEuropean Heart Journal
Volume33
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • Aged
  • Biological Markers
  • C-Reactive Protein
  • Death, Sudden, Cardiac
  • Defibrillators, Implantable
  • Epidemiologic Methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Tachycardia, Ventricular

Fingerprint

Entra nei temi di ricerca di 'Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study'. Insieme formano una fingerprint unica.

Cita questo